Detalhe da pesquisa
1.
Exploring the added value of pretherapeutic MR descriptors in predicting breast cancer pathologic complete response to neoadjuvant chemotherapy.
Eur Radiol
; 33(11): 8142-8154, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37318605